BR0006556A - Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose - Google Patents

Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose

Info

Publication number
BR0006556A
BR0006556A BR0006556-0A BR0006556A BR0006556A BR 0006556 A BR0006556 A BR 0006556A BR 0006556 A BR0006556 A BR 0006556A BR 0006556 A BR0006556 A BR 0006556A
Authority
BR
Brazil
Prior art keywords
phimosis
corticosteroids
treatment
pharmaceutical composition
topical use
Prior art date
Application number
BR0006556-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Paulo Cesar Rodrigues Palma
Original Assignee
Apsen Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apsen Farmaceutica S A filed Critical Apsen Farmaceutica S A
Priority to BR0006556-0A priority Critical patent/BR0006556A/pt
Priority to DE60121047T priority patent/DE60121047T2/de
Priority to PCT/BR2001/000154 priority patent/WO2002053137A2/en
Priority to CNB01822296XA priority patent/CN1270719C/zh
Priority to US10/465,977 priority patent/US7666858B2/en
Priority to EP01272567A priority patent/EP1365766B1/en
Priority to RU2003119439/15A priority patent/RU2279893C2/ru
Priority to JP2002554088A priority patent/JP5095907B2/ja
Priority to ES01272567T priority patent/ES2267671T3/es
Priority to MXPA03005813A priority patent/MXPA03005813A/es
Priority to AU2002221365A priority patent/AU2002221365A1/en
Priority to HK04103871.4A priority patent/HK1060850B/xx
Priority to ARP010106081A priority patent/AR032208A1/es
Publication of BR0006556A publication Critical patent/BR0006556A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR0006556-0A 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose BR0006556A (pt)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose
DE60121047T DE60121047T2 (de) 2000-12-28 2001-12-13 Pharmazeutische zusammensetzung zur behandlung von phimose mit einem topischen corticosteroid
PCT/BR2001/000154 WO2002053137A2 (en) 2000-12-28 2001-12-13 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
CNB01822296XA CN1270719C (zh) 2000-12-28 2001-12-13 利用局部皮质类固醇治疗包茎的药物组合物
US10/465,977 US7666858B2 (en) 2000-12-28 2001-12-13 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
EP01272567A EP1365766B1 (en) 2000-12-28 2001-12-13 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
RU2003119439/15A RU2279893C2 (ru) 2000-12-28 2001-12-13 Фармацевтическая композиция для лечения фимоза путем местного применения кортикостероида
JP2002554088A JP5095907B2 (ja) 2000-12-28 2001-12-13 局所コルチコステロイドを用いた包茎の治療のための医薬組成物
ES01272567T ES2267671T3 (es) 2000-12-28 2001-12-13 Composicion farmaceutica para el tratamiento de fimosis usando corticosteroides topicos.
MXPA03005813A MXPA03005813A (es) 2000-12-28 2001-12-13 Composicion farmaceutica para el tratamiento de fimosis usando corticosteroide topico.
AU2002221365A AU2002221365A1 (en) 2000-12-28 2001-12-13 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
HK04103871.4A HK1060850B (en) 2000-12-28 2001-12-13 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
ARP010106081A AR032208A1 (es) 2000-12-28 2001-12-27 Composicion farmaceutica para uso topico a base de corticosteroides para el tratamiento de la fimosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose

Publications (1)

Publication Number Publication Date
BR0006556A true BR0006556A (pt) 2002-09-17

Family

ID=36686652

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose

Country Status (12)

Country Link
US (1) US7666858B2 (enExample)
EP (1) EP1365766B1 (enExample)
JP (1) JP5095907B2 (enExample)
CN (1) CN1270719C (enExample)
AR (1) AR032208A1 (enExample)
AU (1) AU2002221365A1 (enExample)
BR (1) BR0006556A (enExample)
DE (1) DE60121047T2 (enExample)
ES (1) ES2267671T3 (enExample)
MX (1) MXPA03005813A (enExample)
RU (1) RU2279893C2 (enExample)
WO (1) WO2002053137A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070225670A1 (en) * 2006-03-14 2007-09-27 Connell Thomas J Diapers for improving male genital health and methods of using the same
JP2010519211A (ja) * 2007-02-15 2010-06-03 アラーガン、インコーポレイテッド 膀胱もしくは前立腺障害または多汗症を処置するためのボツリヌス毒素および酵素の使用
CN102933233A (zh) * 2010-06-17 2013-02-13 日东电工株式会社 肾纤维化处理剂
MX348420B (es) 2010-07-20 2017-06-12 Halozyme Inc Efectos secundarios adversos asociados con la administracion de agentes anti-hialuronano y metodos para mejorar o prevenir los efectos secundarios.
CN102302779A (zh) * 2011-07-29 2012-01-04 岳中瑾 治疗包茎的乳膏制剂及其应用
RU2569431C2 (ru) * 2013-07-08 2015-11-27 Александр Васильевич Газаматов Способ консервативного лечения фимоза
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110314168A (zh) * 2019-07-27 2019-10-11 清远市人民医院 一种用于治疗小儿包茎的药物组合物及其制备方法
RU2730476C1 (ru) * 2019-12-24 2020-08-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Противовоспалительная мазь для животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058780C1 (ru) * 1992-11-17 1996-04-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы

Also Published As

Publication number Publication date
ES2267671T3 (es) 2007-03-16
AR032208A1 (es) 2003-10-29
DE60121047T2 (de) 2007-06-21
MXPA03005813A (es) 2005-02-14
EP1365766A2 (en) 2003-12-03
CN1270719C (zh) 2006-08-23
US7666858B2 (en) 2010-02-23
RU2279893C2 (ru) 2006-07-20
WO2002053137A3 (en) 2003-04-24
JP5095907B2 (ja) 2012-12-12
EP1365766B1 (en) 2006-06-21
US20040067922A1 (en) 2004-04-08
DE60121047D1 (de) 2006-08-03
WO2002053137A2 (en) 2002-07-11
RU2003119439A (ru) 2005-02-27
HK1060850A1 (en) 2004-08-27
CN1487833A (zh) 2004-04-07
AU2002221365A1 (en) 2002-07-16
JP2004519451A (ja) 2004-07-02

Similar Documents

Publication Publication Date Title
DK0969813T3 (da) Topisk farmaceutisk sammensætning omfattende et kolinergt middel eller et calciumkanalblokerende middel
MA26843A1 (fr) NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE
BRPI0009956A (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
BR9913945A (pt) Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
BR0107869A (pt) Composições farmacêuticas eletrogiradas
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
BR0311939A (pt) composição farmacêutica, método para tratar inflamação em um mamìfero e uso de uma citocina protetora de tecido orgánico
AR013614A1 (es) Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
MX9700534A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para tratar las enfermedades de prostata, endometriosis y obesidad.
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
BRPI0516531A (pt) imunoterapia de distúrbios auto-imunes
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
Lebwohl Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid
WO2005007072A3 (en) Methods and pharmaceutical compositions for healing wounds
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BRPI0416275A (pt) métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
BR0114665A (pt) Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
BR9711896A (pt) Uso de um inibidor h+,k+atpase e um glicocorticÄide processos para o tratamento de um pÄlipo nasal da sindrome de widal e de asma e formula-{es farmac-uticas para uso sumult-neo separado ou sequencial no tratamento da s¡ndrome de widal e para administra-Æo simult-nea separada ou sequencial no tratamento da asma

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ) , O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 24 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2286 DE 29/10/2014.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI